Login to Your Account

Pivotal trial of Abivax chronic HBV vaccine is under way

By Michael Fitzhugh
Staff Writer

Thursday, February 26, 2015
Abivax SAS dosed the first patient in a pivotal phase IIb/III trial of ABX203, a therapeutic vaccine it's testing against hepatitis B virus (HBV) e-antigen-negative active chronic HBV.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription